Haiyan Jiang
InvestorScientific Advisory Group Member at Pathway to Cures
Find your path to Haiyan
19 people in our graph share verified history with Haiyan — schools, employers, funds. One of them is your warm intro.
Teri WilleyunlockedHaiyan: together at Pathway to Cures
×11Haiyan: together at Pathway to Cures
About
Jiang is co-founder and Chief Scientific Officer at PointLoma BioSciences, with deep experience in cell and gene therapy. She contributed to development of therapies at Editas Medicine, Biogen, and Bayer.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Frequently asked questions
- Who is Haiyan Jiang?
- Jiang is co-founder and Chief Scientific Officer at PointLoma BioSciences, with deep experience in cell and gene therapy. She contributed to development of therapies at Editas Medicine, Biogen, and Bayer.
- Where does Haiyan Jiang work?
- Haiyan Jiang is Scientific Advisory Group Member at Pathway to Cures.